glp-1 updates Clinical Practice Updates: February 2026 Key Developments Market Overview: GLP-1 Agonists and

One of the latest advancements is the use of GLP-1 receptor agonists (GLP-1 RAs) have gained popularity in the past few years for weight loss in obese and overweight individuals

It deeply moisturizes, soothes dryness, and reduces fine lines, wrinkles, and sagging

Medicare is barred from covering drugs that treat weight loss alone

But it is changing unevenly, and without deliberate policy intervention, the GLP-1 revolution risks becoming one of the starkest examples in modern medicine of a breakthrough that transformed outcomes for those who could afford it, and passed everyone else by.

What the New Study Found The study reviewed health records from more than 26,000 adults